Swedish Orphan Biovitrum ... (BIOVF)

PNK: BIOVF · Real-Time Price · USD

30.66

0.00 (0.00%)

At close: Apr 30, 2025, 10:30 AM

Swedish Orphan Biovitrum AB (publ) Balance Sheet Statement

Financials in SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.14B	904M	1.36B	1.04B	404M	737M	3B	1.48B	785.79M
Short-Term Investments	n/a	105M	-9M	-9M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	37M	121M	199M	179M	50M	55.44M	35.16M	1.96M
Other Long-Term Assets	434M	2.08B	n/a	1M	-1M	-2M	n/a	n/a	n/a
Receivables	7.86B	n/a	6.14B	4.31B	4.71B	4.81B	2.17B	1.52B	1.05B
Inventory	4.16B	3.87B	3.33B	3.42B	3.05B	1.77B	1.28B	1.05B	870.05M
Other Current Assets	1M	7.06B	6.14B	4.11B	4.53B	4.62B	2.17B	1.52B	1.13B
Total Current Assets	13.16B	12.67B	11.21B	8.78B	8.17B	7.32B	6.6B	4.16B	2.91B
Property-Plant & Equipment	1.58B	251M	274M	493M	535M	519M	136.3M	134.18M	121.02M
Goodwill & Intangibles	58.97B	58.98B	40.01B	38.42B	38.79B	37.41B	10.16B	6.45B	6.81B
Total Long-Term Assets	62.28B	61.36B	41.28B	39.88B	40.12B	38.34B	10.58B	6.75B	7.06B
Total Assets	75.44B	74.03B	52.5B	48.66B	48.28B	45.66B	17.18B	10.9B	9.97B
Account Payables	944M	1.02B	1.25B	558M	569M	681M	487M	358.45M	280.17M
Deferred Revenue	n/a	n/a	3.13B	5.28B	5.04B	3.4B	28.83M	1.34B	825.1M
Short-Term Debt	3.93B	8.81B	5.8B	1.77B	4.01B	n/a	n/a	579.89M	496.7M
Other Current Liabilities	7.6B	8.81B	7.29B	6.02B	4.91B	4.29B	2.28B	509.56M	952.97M
Total Current Liabilities	12.6B	19.09B	14.86B	8.76B	10.44B	5.74B	6.95B	2.36B	1.76B
Long-Term Debt	12.41B	11.36B	2.97B	8.78B	10.14B	16.14B	n/a	1.07B	502.22M
Other Long-Term Liabilities	3.17B	9.54B	7.94B	7.44B	6.94B	6.35B	1.19B	765.69M	2.36B
Total Long-Term Liabilities	22.55B	21.07B	11.11B	16.7B	17.63B	22.99B	1.19B	1.84B	2.86B
Total Liabilities	35.15B	40.16B	25.97B	25.46B	28.08B	28.73B	8.14B	4.2B	4.62B
Total Debt	16.73B	20.48B	9.1B	10.91B	14.57B	16.56B	2.99M	1.65B	2.81B
Common Stock	195M	194M	170M	169M	167M	165M	149.97M	149.53M	149.25M
Retained Earnings	21.92B	18.05B	15.79B	13.15B	10.48B	7.27B	3.97B	1.55B	388.8M
Comprehensive Income	n/a	n/a	351M	-66M	-253M	-202M	-144.3M	-20.39M	-167.73M
Shareholders Equity	40.29B	33.87B	26.52B	23.2B	20.21B	16.93B	9.04B	6.7B	5.35B
Total Investments	166M	83M	112M	190M	179M	50M	55.44M	35.16M	1.96M